Works matching DE "EMTRICITABINE-tenofovir"
Results: 350
HIV post-exposure prophylaxis in the Emergency Department: a perspective from Singapore.
- Published in:
- Proceedings of Singapore Healthcare, 2019, v. 28, n. 3, p. 167, doi. 10.1177/2010105819841391
- By:
- Publication type:
- Article
Acute Vision Loss in a 35-Year-old Woman.
- Published in:
- 2025
- By:
- Publication type:
- Case Study
Pre-exposure Prophylaxis for Transgender People: A Systematic Review.
- Published in:
- 2025
- By:
- Publication type:
- Letter to the Editor
Evaluation of chromatographic conditions for simultaneously determination of Emtricitabine and Tenofovir.
- Published in:
- Macedonian Pharmaceutical Bulletin / Makedonsko Farmacevtski Bilten, 2022, v. 68, p. 101, doi. 10.33320/maced.pharm.bull.2022.68.03.046
- By:
- Publication type:
- Article
Capturing public interest toward new tools for controlling human immunodeficiency virus (HIV) infection exploiting data from Google Trends.
- Published in:
- Health Informatics Journal, 2019, v. 25, n. 4, p. 1383, doi. 10.1177/1460458218766573
- By:
- Publication type:
- Article
Preexposure Prophylaxis: Adapting HIV Prevention Models to Achieve Worldwide Access.
- Published in:
- American Journal of Public Health, 2017, v. 107, n. 10, p. 1534, doi. 10.2105/AJPH.2017.304035
- By:
- Publication type:
- Article
How Stigma Surrounding the Use of HIV Preexposure Prophylaxis Undermines Prevention and Pleasure: A Call to Destigmatize "Truvada Whores".
- Published in:
- 2015
- By:
- Publication type:
- Opinion
HIV Prevention in Clinical Care Settings.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 4, p. 390, doi. 10.1001/jama.2014.7999
- By:
- Publication type:
- Article
Study Halted: No Benefit Seen From Antiretroviral Pill in Preventing HIV in Women.
- Published in:
- JAMA: Journal of the American Medical Association, 2011, v. 305, n. 19, p. 1952, doi. 10.1001/jama.2011.649
- By:
- Publication type:
- Article
Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial.
- Published in:
- Trials, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s13063-021-05758-9
- By:
- Publication type:
- Article
INNOVATION TO CONTAIN THE HIV/AIDS CRISIS: A TRUVADA CASE STUDY.
- Published in:
- Berkeley Technology Law Journal, 2024, v. 39, p. 425, doi. 10.15779/Z38FX7402G
- By:
- Publication type:
- Article
Postexposure prophylaxis for HIV: Pivotal intervention for those at risk.
- Published in:
- JAAPA: Journal of the American Academy of Physician Assistants (Haymarket Media, Inc.), 2011, v. 24, n. 8, p. 22, doi. 10.1097/01720610-201108000-00005
- By:
- Publication type:
- Article
Hydroxyzine Use and Mortality in Patients Hospitalized for COVID-19: A Multicenter Observational Study.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5891, doi. 10.3390/jcm10245891
- By:
- Publication type:
- Article
Improvement in insulin sensitivity after switching from an integrase inhibitor‐based regimen to doravirine/tenofovir disoproxil fumarate/lamivudine in people with significant weight gain.
- Published in:
- HIV Medicine, 2024, v. 25, n. 8, p. 919, doi. 10.1111/hiv.13644
- By:
- Publication type:
- Article
Twelve‐month effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV: Real‐world insights from BICSTaR cohorts.
- Published in:
- HIV Medicine, 2024, v. 25, n. 4, p. 440, doi. 10.1111/hiv.13593
- By:
- Publication type:
- Article
Weight gain following the single substitution of tenofovir disoproxil fumarate by tenofovir alafenamide in HIV‐infected people from the French Dat'AIDS cohort: A propensity score‐matched analysis.
- Published in:
- HIV Medicine, 2023, v. 24, n. 8, p. 925, doi. 10.1111/hiv.13488
- By:
- Publication type:
- Article
PrEP for women in Europe: a systematic literature review.
- Published in:
- HIV Medicine, 2023, v. 24, n. 7, p. 765, doi. 10.1111/hiv.13458
- By:
- Publication type:
- Article
BHIVA guidelines on antiretroviral treatment for adults living with HIV‐1 2022.
- Published in:
- HIV Medicine, 2022, v. 23, p. 3, doi. 10.1111/hiv.13446
- By:
- Publication type:
- Article
Major revision version 11.0 of the European AIDS Clinical Society Guidelines 2021.
- Published in:
- HIV Medicine, 2022, v. 23, n. 8, p. 849, doi. 10.1111/hiv.13268
- By:
- Publication type:
- Article
Bone mineral density, kidney function, weight gain and insulin resistance in women who switch from TDF/FTC/NNRTI to ABC/3TC/DTG.
- Published in:
- HIV Medicine, 2021, v. 22, n. 2, p. 83, doi. 10.1111/hiv.12961
- By:
- Publication type:
- Article
Once‐daily raltegravir with tenofovir disoproxil/emtricitabine as HIV post‐exposure prophylaxis following sexual exposure.
- Published in:
- HIV Medicine, 2021, v. 22, n. 2, p. e5, doi. 10.1111/hiv.12938
- By:
- Publication type:
- Article
Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
- Published in:
- HIV Medicine, 2021, v. 22, n. 1, p. 67, doi. 10.1111/hiv.12960
- By:
- Publication type:
- Article
Post‐exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV*.
- Published in:
- HIV Medicine, 2020, v. 21, n. 7, p. 463, doi. 10.1111/hiv.12880
- By:
- Publication type:
- Article
The potential role of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) single‐tablet regimen in the expanding spectrum of fixed‐dose combination therapy for HIV.
- Published in:
- HIV Medicine, 2020, v. 21, p. 3, doi. 10.1111/hiv.12833
- By:
- Publication type:
- Article
Sexually transmitted infection testing and rates in men who have sex with men (MSM) using HIV pre‐exposure prophylaxis.
- Published in:
- 2019
- By:
- Publication type:
- Letter to the Editor
BHIVA/BASHH guidelines on the use of HIV pre–exposure prophylaxis (PrEP) 2018.
- Published in:
- HIV Medicine, 2019, v. 20, p. s2, doi. 10.1111/hiv.12718
- Publication type:
- Article
HIV health care providers are ready to introduce pre‐exposure prophylaxis in Central and Eastern Europe and neighbouring countries: data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group.
- Published in:
- HIV Medicine, 2018, v. 19, n. 9, p. 629, doi. 10.1111/hiv.12641
- By:
- Publication type:
- Article
First‐line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison.
- Published in:
- HIV Medicine, 2018, v. 19, n. 7, p. 475, doi. 10.1111/hiv.12628
- By:
- Publication type:
- Article
InterPrEP: internet-based pre-exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London - analysis of pharmacokinetics, safety and outcomes.
- Published in:
- HIV Medicine, 2018, v. 19, n. 1, p. 1, doi. 10.1111/hiv.12528
- By:
- Publication type:
- Article
Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 482, doi. 10.1111/hiv.12479
- By:
- Publication type:
- Article
Plasma trough concentrations of darunavir/ritonavir and raltegravir in older patients with HIV-1 infection.
- Published in:
- HIV Medicine, 2017, v. 18, n. 7, p. 474, doi. 10.1111/hiv.12478
- By:
- Publication type:
- Article
Virological responses to lamivudine or emtricitabine when combined with tenofovir and a protease inhibitor in treatment-naïve HIV-1-infected patients in the Dutch AIDS Therapy Evaluation in the Netherlands ( ATHENA) cohort.
- Published in:
- HIV Medicine, 2016, v. 17, n. 8, p. 571, doi. 10.1111/hiv.12355
- By:
- Publication type:
- Article
Comparative risk of failure of ABC/3 TC or TDF/ FTC based first-line regimens in patients with a high viral load.
- Published in:
- HIV Medicine, 2016, v. 17, n. 5, p. 380, doi. 10.1111/hiv.12306
- By:
- Publication type:
- Article
Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.
- Published in:
- HIV Medicine, 2015, v. 16, n. 6, p. 370, doi. 10.1111/hiv.12210
- By:
- Publication type:
- Article
Pharmacokinetics of tenofovir during pregnancy and postpartum.
- Published in:
- HIV Medicine, 2015, v. 16, n. 8, p. 502, doi. 10.1111/hiv.12252
- By:
- Publication type:
- Article
Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy.
- Published in:
- HIV Medicine, 2014, v. 15, n. 10, p. 611, doi. 10.1111/hiv.12157
- By:
- Publication type:
- Article
Raltegravir-emtricitabine-tenofovir as HIV nonoccupational post-exposure prophylaxis in men who have sex with men: safety, tolerability and adherence.
- Published in:
- HIV Medicine, 2014, v. 15, n. 1, p. 13, doi. 10.1111/hiv.12075
- By:
- Publication type:
- Article
Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study Impact of switching from zidovudine/lamivudine to tenofovir/emtricitabine on lipoatrophy: the RECOMB study.
- Published in:
- HIV Medicine, 2013, v. 14, n. 6, p. 327, doi. 10.1111/hiv.12011
- By:
- Publication type:
- Article
Pre-exposure prophylaxis for sexually-acquired HIV risk management: a review.
- Published in:
- HIV/AIDS - Research & Palliative Care, 2015, v. 7, p. 125, doi. 10.2147/HIV.S50025
- By:
- Publication type:
- Article
Critical appraisal of elvitegravir in the treatment of HIV-1/AIDS.
- Published in:
- HIV/AIDS - Research & Palliative Care, 2014, v. 6, p. 81, doi. 10.2147/HIV.S39178
- By:
- Publication type:
- Article
New option for management of HIV-1 infection in treatment-naive patients: once-daily, fixed-dose combination of rilpivirine-emtricitabine-tenofovir.
- Published in:
- HIV/AIDS - Research & Palliative Care, 2012, v. 4, p. 61
- By:
- Publication type:
- Article
Line-field confocal optical coherence tomography for real-time differential diagnosis of toxic epidermal necrolysis versus staphylococcal scalded skin syndrome.
- Published in:
- Clinical & Experimental Dermatology, 2024, v. 49, n. 12, p. 1704, doi. 10.1093/ced/llae247
- By:
- Publication type:
- Article
The Americas.
- Published in:
- Journal of Global Health, 2012, v. 2, n. 1, p. 4, doi. 10.7189/jogh.02.010201
- Publication type:
- Article
Simultaneous Spectrophotometric Method for Determination of Emtricitabine and Tenofovir Disoproxil Fumarate in Three-Component Tablet Formulation Containing Rilpivirine Hydrochloride.
- Published in:
- ISRN Otolaryngology, 2014, p. 1, doi. 10.1155/2014/541727
- By:
- Publication type:
- Article
High uptake of pre-exposure prophylaxis (PrEP) during early roll-out in Belgium: results from surveillance reports.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Getting pre-exposure prophylaxis (PrEP) to the people: opportunities, challenges and emerging models of PrEP implementation.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Mediated intimacies: Raw sex, Truvada, and the biopolitics of chemoprophylaxis.
- Published in:
- Sexualities, 2015, v. 18, n. 1/2, p. 224, doi. 10.1177/1363460715569137
- By:
- Publication type:
- Article
Estimating Efficacy in a Randomized Trial With Product Nonadherence: Application of Multiple Methods to a Trial of Preexposure Prophylaxis for HIV Prevention.
- Published in:
- American Journal of Epidemiology, 2015, v. 182, n. 10, p. 848, doi. 10.1093/aje/kwv202
- By:
- Publication type:
- Article
Zidovudina/Lamivudina vs Abacavir/Lamivudina vs Tenofovir/Emtricitabina en combinaciones de dosis fija como tratamiento inicial en pacientes con VIH: revisión sistemática y metanálisis en red.
- Published in:
- Colombia Medica, 2017, v. 48, n. 2, p. 70
- By:
- Publication type:
- Article
From trials to the public health: pre-exposure prophylaxis for HIV prevention.
- Published in:
- 2013
- By:
- Publication type:
- Opinion